Guardant Health (GH) Tops Q3 EPS by 40c, Offers Guidance

Guardant Health (NASDAQ: GH) reported Q3 EPS of ($0.39), $0.40 better than the analyst estimate of ($0.79). Revenue for the quarter came in at $265.2 million versus the consensus estimate of $235.64 million.

GUIDANCE:

Guardant Health sees Q4 2025 revenue of $935-970 million, versus the consensus of $922 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Morgan Stanley Upgrades Demant A/S (DEMANT:DC) (WILYY) to Overweight
• Active options: TSLA NVDA AMZN GOOGL AAPL SPCX MSFT NFLX INTC